🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to assess the immunogenicity, safety and reactogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05568797
Treatments Being Tested
A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Status
Completed
Location
MHAT St. Ekaterina
Start Date
2016-09-30
Trial ID
NCT02587221
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02255409
Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit I...
Status
Completed
Location
222, Novartis Investigational Site
Start Date
2013-11
Trial ID
NCT01964989
This is a Phase 3, randomized, parallel-group, comparator-controlled, obser...
Status
Completed
Location
Alliance for Multispecialty Research (AMR) Phoenix
Start Date
2023-11-03
Trial ID
NCT06015282
Treatments Being Tested
This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted...
Status
Completed
Location
84046-Accel Research Sites - Birmingham
Start Date
2023-10-23
Trial ID
NCT06087640
Treatments Being Tested
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...
Status
Completed
Location
Investigational Site- 001
Start Date
2016-01-29
Trial ID
NCT02583256
Treatments Being Tested
This Phase 3 study is a randomized, observer-blind immunogenicity and safet...
Status
Completed
Location
84013 Coastal Clinical Research, Inc.
Start Date
2021-09-30
Trial ID
NCT05044195
Treatments Being Tested